| 3VU5 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | ACE, NH2, NH4, SO4 | enzyme |
| ||||||||||||
| Primary reference | Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1., Chong H, Yao X, Qiu Z, Sun J, Zhang M, Waltersperger S, Wang M, Liu SL, Cui S, He Y, FASEB J. 2013 Mar;27(3):1203-13. doi: 10.1096/fj.12-222547. Epub 2012 Dec 11. PMID:23233535 | ||||||||||||||
| Data retrieval |
![]() |
| View 3VU5 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |